In addition, some cases of MDS with fibrosis have been associated with a JAK2 V617F mutation suggesting that this may be responsible for myelofibrosis in a subset of MDS cases, postulating a possible myeloproliferative biology background [18]. This evidence concerns the gene JAK2 and myelodysplastic syndrome.